A dual cardiomyocyte reporter model derived from human pluripotent stem cells

Yuqian Jiang1, Xiaoping Bao2, Xiaojun Lance Lian3,4,5

  • 1Department of Biomedical Engineering, Pennsylvania State University, University Park, PA, 16802, USA.

Insights

Researchers developed a new human pluripotent stem cell (hPSC) line to isolate and study cardiomyocytes (CMs). This dual reporter system aids in cardiovascular disease (CVD) research and drug discovery.

Area of Science:

  • Stem cell biology
  • Cardiovascular research
  • Biotechnology

Background:

  • Cardiovascular diseases (CVD) are a major cause of mortality.
  • Human pluripotent stem cells (hPSCs) offer potential for regenerative medicine, disease modeling, and drug screening.
  • Efficient methods for isolating and characterizing cardiomyocytes (CMs) are crucial for these applications.

Purpose of the Study:

  • To establish a novel human pluripotent stem cell (hPSC) line for the purification and characterization of cardiomyocytes (CMs).
  • To create a dual reporter system for enhanced CM analysis.
  • To facilitate advancements in cardiovascular disease (CVD) modeling and drug discovery.

Main Methods:

  • Generation of an hPSC line with a mCherry fluorescent protein reporter under the alpha myosin heavy chain (aMHC) promoter.
  • Integration of a fluorescent voltage indicator (ASAP2f) for dual-color imaging.
  • Utilizing fluorescence to purify and characterize CM subtypes.

Main Results:

  • Successful establishment of a dual reporter hPSC line enabling CM purification via aMHC promoter activity.
  • Demonstration of the platform's capability for characterizing CM subtypes.
  • Validation of the dual reporter system for potential use in CVD research.

Conclusions:

  • The developed dual reporter hPSC platform provides a robust tool for cardiomyocyte purification and characterization.
  • This system holds significant promise for advancing cardiovascular disease modeling and therapeutic discovery.
  • The technology enables precise analysis of cardiomyocyte subtypes for targeted research.